CAR--话题@MedSci

#CAR-#

459篇内容 | 2264人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781200, encodeId=19cd1e8120059, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature重磅：CAR-T治疗多发性骨髓瘤又添特异性新靶点，临床前研究结果安全有效, objectType=article, longId=122737, objectId=9547122e371f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9547122e371f, replyNumber=0, likeNumber=136, createdTime=2018-04-25, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9547122e371f, moduleTitle=Nature重磅：CAR-T治疗多发性骨髓瘤又添特异性新靶点，临床前研究结果安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9547122e371f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781162, encodeId=834d1e8116201, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=两项重磅CAR-T疗法临床2期结果同时出炉, objectType=article, longId=103680, objectId=c11110368067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c11110368067, replyNumber=0, likeNumber=64, createdTime=2017-09-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c11110368067, moduleTitle=两项重磅CAR-T疗法临床2期结果同时出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c11110368067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781155, encodeId=85841e8115558, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=意外！Kite制药CAR-T疗法KTE-C19出现1例患者死亡, objectType=article, longId=98381, objectId=23529838182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23529838182, replyNumber=0, likeNumber=63, createdTime=2017-12-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23529838182, moduleTitle=意外！Kite制药CAR-T疗法KTE-C19出现1例患者死亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23529838182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781213, encodeId=e8841e8121369, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：CAR-T治疗ALL白血病患者的12个月总生存率达76%, objectType=article, longId=128576, objectId=44161285e661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44161285e661, replyNumber=0, likeNumber=67, createdTime=2018-06-05, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44161285e661, moduleTitle=NEJM：CAR-T治疗ALL白血病患者的12个月总生存率达76%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44161285e661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781161, encodeId=61b91e8116144, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=艾森技术新突破与美国著名癌症中心合作研究CAR-T免疫治疗, objectType=article, longId=101604, objectId=d82210160453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82210160453, replyNumber=0, likeNumber=55, createdTime=2018-01-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82210160453, moduleTitle=艾森技术新突破与美国著名癌症中心合作研究CAR-T免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82210160453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781197, encodeId=b16b1e8119747, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=博雅解读：全球首条全自动、全封闭的CAR-T细胞CMC生产线, objectType=article, longId=121774, objectId=4810121e74ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4810121e74ed, replyNumber=0, likeNumber=55, createdTime=2017-12-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4810121e74ed, moduleTitle=博雅解读：全球首条全自动、全封闭的CAR-T细胞CMC生产线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4810121e74ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781196, encodeId=c5ff1e8119655, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生, objectType=article, longId=121305, objectId=8705121305a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8705121305a7, replyNumber=0, likeNumber=68, createdTime=2018-05-19, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8705121305a7, moduleTitle=CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8705121305a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781192, encodeId=184a1e811920e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=天津血液肿瘤高峰论坛：梁爱斌教授分享CAR-T研发的经验和思考, objectType=article, longId=119395, objectId=bd2011939511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd2011939511, replyNumber=0, likeNumber=71, createdTime=2018-07-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd2011939511, moduleTitle=天津血液肿瘤高峰论坛：梁爱斌教授分享CAR-T研发的经验和思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd2011939511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781189, encodeId=74ba1e811899f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=博雅, 赛斯卡医疗, CAR-T, objectType=article, longId=115642, objectId=230d11564227, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=230d11564227, replyNumber=0, likeNumber=63, createdTime=2018-07-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=230d11564227, moduleTitle=博雅, 赛斯卡医疗, CAR-T, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=230d11564227)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781181, encodeId=9b221e81181ac, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=第三届全球CAR-T峰会开幕在即，中国企业受邀出席大会, objectType=article, longId=111885, objectId=d2b91118856e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b91118856e, replyNumber=0, likeNumber=83, createdTime=2017-10-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b91118856e, moduleTitle=第三届全球CAR-T峰会开幕在即，中国企业受邀出席大会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2b91118856e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781211, encodeId=e7551e8121189, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=PNAS：研究人员开发出可以远程控制的CAR-T细胞免疫治疗系统！, objectType=article, longId=127111, objectId=75ab12e11115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75ab12e11115, replyNumber=0, likeNumber=72, createdTime=2018-11-12, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75ab12e11115, moduleTitle=PNAS：研究人员开发出可以远程控制的CAR-T细胞免疫治疗系统！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75ab12e11115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781173, encodeId=85391e81173af, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Kite多发性骨髓瘤CAR-T疗法获美FDA批准, objectType=article, longId=108224, objectId=e2a810822478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a810822478, replyNumber=0, likeNumber=83, createdTime=2018-06-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a810822478, moduleTitle=Kite多发性骨髓瘤CAR-T疗法获美FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a810822478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781201, encodeId=4edf1e812017d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=鲍慧铮教授：CAR-T治疗在血液系统肿瘤中的研究进展, objectType=article, longId=123555, objectId=2ba812355560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ba812355560, replyNumber=0, likeNumber=82, createdTime=2018-05-14, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ba812355560, moduleTitle=鲍慧铮教授：CAR-T治疗在血液系统肿瘤中的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ba812355560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781185, encodeId=39f81e81185c6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell Res：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤, objectType=article, longId=113416, objectId=4e7611341602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e7611341602, replyNumber=0, likeNumber=68, createdTime=2017-10-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e7611341602, moduleTitle=Cell Res：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e7611341602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781163, encodeId=eea91e8116395, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐, objectType=article, longId=105399, objectId=1de4105399b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1de4105399b0, replyNumber=0, likeNumber=68, createdTime=2017-09-15, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1de4105399b0, moduleTitle=CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1de4105399b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781183, encodeId=c3a01e811839f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=全球CAR-细胞疗法获批上市，一个新时代的到来？, objectType=article, longId=112302, objectId=1335112302bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1335112302bd, replyNumber=0, likeNumber=53, createdTime=2017-11-19, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1335112302bd, moduleTitle=全球CAR-细胞疗法获批上市，一个新时代的到来？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1335112302bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781193, encodeId=8b741e8119398, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T市场呈指数增长，人类进入新的医学创新前沿, objectType=article, longId=120307, objectId=0be512030ec9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0be512030ec9, replyNumber=0, likeNumber=64, createdTime=2018-06-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0be512030ec9, moduleTitle=CAR-T市场呈指数增长，人类进入新的医学创新前沿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0be512030ec9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781170, encodeId=e7f51e811704f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle= SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服, objectType=article, longId=106825, objectId=e4dc106825f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4dc106825f0, replyNumber=0, likeNumber=79, createdTime=2017-11-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4dc106825f0, moduleTitle= SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4dc106825f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781158, encodeId=a54b1e811581f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature：让CAR-T疗法更“牛”，这10个方向或许你该看看, objectType=article, longId=100975, objectId=641e1009e50a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=641e1009e50a, replyNumber=0, likeNumber=78, createdTime=2018-03-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=641e1009e50a, moduleTitle=Nature：让CAR-T疗法更“牛”，这10个方向或许你该看看, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=641e1009e50a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781159, encodeId=184a1e81159ea, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法JCAR015失败，JUNO公司数千万美元打水漂, objectType=article, longId=101037, objectId=bb6d10103ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6d10103ee8, replyNumber=0, likeNumber=105, createdTime=2018-04-24, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6d10103ee8, moduleTitle=CAR-T疗法JCAR015失败，JUNO公司数千万美元打水漂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6d10103ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nature重磅：CAR-T治疗多发性骨髓瘤又添特异性新靶点，临床前研究结果安全有效

2018-04-25

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

两项重磅CAR-T疗法临床2期结果同时出炉

2017-09-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

意外！Kite制药CAR-T疗法KTE-C19出现1例患者死亡

2017-12-22

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：CAR-T治疗ALL白血病患者的12个月总生存率达76%

2018-06-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

艾森技术新突破与美国著名癌症中心合作研究CAR-T免疫治疗

2018-01-09

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

博雅解读：全球首条全自动、全封闭的CAR-T细胞CMC生产线

2017-12-15

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞疗法金矿急待开发，全球自动化铁锹诞生

2018-05-19

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

天津血液肿瘤高峰论坛：梁爱斌教授分享CAR-T研发的经验和思考

2018-07-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

博雅, 赛斯卡医疗, CAR-T

2018-07-01

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

第三届全球CAR-T峰会开幕在即，中国企业受邀出席大会

2017-10-14

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

PNAS：研究人员开发出可以远程控制的CAR-T细胞免疫治疗系统！

2018-11-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Kite多发性骨髓瘤CAR-T疗法获美FDA批准

2018-06-09

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

鲍慧铮教授：CAR-T治疗在血液系统肿瘤中的研究进展

2018-05-14

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell Res：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤

2017-10-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法里程碑：诺华CTL-019获10:0全票通过，FDA专家一致推荐

2017-09-15

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

全球CAR-细胞疗法获批上市，一个新时代的到来？

2017-11-19

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T市场呈指数增长，人类进入新的医学创新前沿

2018-06-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

SCI TRANSL MED :大牛Carl June参与发表论文：CAR-T治疗实体瘤“人体试验”结果公布，有两大障碍需克服

2017-11-04

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature：让CAR-T疗法更“牛”，这10个方向或许你该看看

2018-03-03

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法JCAR015失败，JUNO公司数千万美元打水漂

2018-04-24

科室
- - 订阅+
  - 更多科室
工具
服务